Researchers at Kumamoto University have demonstrated that lysine-specific demethylase 1 (LSD1) shapes the variation in metabolic phenotypes seen in distinct […]
After a six-year wait, the world’s largest Genomics and Biodata event is making its highly anticipated return to Boston! Join […]
After taking things digital for the past 2 years, the UK’s largest genomics event is back – and back to […]
Front Line Genomics is pleased to announce the first Tri-Omics Summit in London on 18th – 20th October 2022. The […]
Front Line Genomics is pleased to announce the first Tri-Omics Summit in Boston, MA on September 27th – 29th 2022. […]
With drug discovery being an expensive process and genetic-based drugs being more likely to succeed, the level of investment in […]
A recent study has explored the concept of a modern and collaborative approach to data-driven drug development called Translational Precision […]
Recent DNA/RNA sequencing and other multi-omics technologies have advanced our understanding of the biology and pathophysiology of Alzheimer’s disease. However, […]
Despite an increase in investment into R&D from biopharma companies, only 5-10% of drugs that enter early-stage clinical trials ever […]
A recent article, published in Communications Biology, has outlined a method for expanding our understanding of host-microbiome interactions that will […]
